The Supreme Court is being asked to intervene to prevent the Fifth Circuit's ruling from blocking the FDA's policy that allows the mailing of mifepristone, a medication abortion drug.
Claims
The Supreme Court is being asked to intervene to prevent the Fifth Circuit's ruling from blocking the FDA's policy that allows the mailing of mifepristone, a medication abortion drug.
Parent: HealthcareEntity: MifepristoneImpact: negativeDate: May 2, 2026Target: The Supreme Court's decision on whether to block the Fifth Circuit's ruling against the FDA's policy allowing the mailing of mifepristone.
Source posts
BREAKING: Danco Laboratories, maker of Mifeprex, goes to the Supreme Court, seeking an immediate stay of the Fifth Circuit's Friday mifepristone ruling.
Under the Fifth Circuit ruling, FDA's rule that allowed mailing of the medication abortion drug is to be blocked.
More to come: https://www.lawdork.com/
6 boosts · 0 favs · 3 replies · May 2, 2026
BREAKING: Mifepristone is back at the Supreme Court in case over mailing the medication abortion drug.
After a Fifth Circuit ruling Friday that would end the mailing of mifepristone, a drugmaker asked SCOTUS to act immediately to keep the FDA policy allowing mailing in place.
New, at Law Dork: https://www.lawdork.com/p/mifepristone-supreme-court-return-mailing
13 boosts · 0 favs · 4 replies · May 2, 2026